NEW YORK, April 27, 2017 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it will report its first quarter 2017 financial results prior to the NASDAQ market open on Thursday, May 4, 2017. Intercept management will conduct a conference call and audio webcast on Thursday, May 4, 2017 at 8:30 a.m. Eastern Time to discuss these results.
Intercept management will also be presenting at the following investor conference:
- Bank of America Merrill Lynch 2017 Healthcare Conference on May 17, 2017 at 5:00 p.m. Pacific Time
Webcast information for these events will be available on the Investors page of Intercept's website at http://ir.interceptpharma.com. Archived webcasts will be available on Intercept's website for approximately two weeks.
About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia. Founded in 2002 in New York, Intercept now has operations in the United States, Europe and Canada.
CONTACT: For more information about Intercept Pharmaceuticals, please contact: Intercept Pharmaceuticals: Mark Vignola +1-646-747-1000 [email protected] Media inquiries: [email protected] Investor inquiries: [email protected]


Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation
BHP Posts Record Iron Ore Output as China Pricing Pressures Loom
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10%
OpenAI Launches Stargate Community Plan to Offset Energy Costs and Support Local Power Infrastructure
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand
Lululemon Founder Chip Wilson Escalates Proxy Fight to Remove Advent From Board
Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer
Trump Signs Executive Order to Limit Wall Street Investment in Single-Family Homes
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production
Rio Tinto Posts Strong Q4 Iron Ore and Copper Output on Operational Recovery
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 



